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Green tea, as a commonly consumed beverage worldwide, has a long history of use as 
a dietary supplement for various conditions. Green tea products have been shown to 
possess various biological activities, ranging from cardiovascular protection to 
anticancer effects. The bioactivity of green tea is largely attributed to catechin 
polyphenols, which make up around on third of the dry leaf weight of green tea. 
However, the quality of green tea is variable, which may be attributed to the variation 
in contents of the catechins and other polyphenols, thus the content of these 
polyphenols may be a suitable determinant of the quality of green tea.  The aims of 
this project are to develop analytical methods to determine the concentration of 
antioxidant compounds in various green tea products, as well as their antioxidant 
activities.  The findings may be useful for the assessment of green tea product quality 
and used for quality control of green tea products.  
Eleven (11) commercial green tea products were sourced from the local market, 
including dried tea leaves, tea powders and TGA listed tablets and sachet. The green 
tea products were extracted and subjected to HPLC analysis of selected chemical 
markers, using a Shimadzu HPLC with a photo-diode array detector, and LC-MS 
analysis, using a Waters Xevo TQ with electrospray ionisation source and Waters 
Aquity UPLC. An in vitro DPPH radical scavenging assay was used to determine the 
antioxidant activity of green tea samples. The total phenolic content (TPC) was 
determined using the Folin Ciocalteu (FC) method. In addition, an online antioxidant 
screening assay was developed using HPLC and post column derivatization.   
The chemical markers , gallic acid, gallocatechin, theobromine, epigallocatechin, 
epigallocatechin gallate, caffeine, epcatechin and epicatechin gallate in the green tea 
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samples were quantified by HPLC. The content of each marker compound varied in 
different green tea products. The highest contents of markers were observed for a TGA 
listed product (S11), while the lowest content was also observed for another sachet 
product (S10). Among the different products, the traditional tea leaf products (S3, S4, 
S5, S6 and S7) showed a higher level of marker contents than the tea powder products 
(Matcha, S1 and S2). In addition, the content of L-theanine, determined by LC-MS, 
varied significantly among different products, with the highest level observed in 
sample 7 and 5, followed by Sample 1. L-theanine was not detectable in TGA listed 
green tea tablets (S8 and S9), indicating that the manufacture procedure may affect the 
level of L-theanine in the final product. These results indicate that the level of marker 
compounds varies significantly among different green tea products. It is surprising to 
observe that one green tea sachet product (S10), which claimed (on packaging) to be 
potent and equal up to 20 cups of green tea per sachet is actually the less potent among 
the products tested- including the raw teas. Thus the consumer should be wary when 
choosing the green tea products based on the product labels. More random testing 
should be conducted by the regulatory authorities to ensure the listed products have 
quality matching their labels. 
Similar results were obtained for the antioxidant activity of green tea products, with 
the highest antioxidant activity observed for S11, followed by S9 and S8, and the 
lowest antioxidant activity was observed for the green tea sachet product (S10), 
indicating the antioxidant activity of the green tea products is related to the content of 
marker compounds studied. This is further supported by series of correlation analysis 
which showed a significant positive correlation between the total content of group 
catechin markers (GA, EGC, EC, ECG) with the antioxidant activity, indicating these 
compounds may directly link to the antioxidant activity of green tea products. In 
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contrast, other compounds present in tea, methylxanthines, caffeine and theobromine, 
showed no a correlation with the antioxidant activity. Similar results were obtained for 
L-theanine, no correlation was observed for its content with the antioxidant activity. 
These results indicate that there is a strong correlation between the concentrations of 
selected catechin marker compounds in the tea samples and the antioxidant activity in 
vitro. 
Finally, a specific online assay has been developed with efficient separations and clear 
antioxidant responses. It is also consistent with the results of the in vitro antioxidant 
activity assay, with the markers (eg GA, EC, EGC and EGCG) strongly correlated with 
the in vitro anti-oxidant activity also found to be active in the online FRAP assay. 
Thus, the online method is efficient to identify known or unknown 
component/compounds with antioxidant activities. This approach is potentially a 
powerful tool to study the antioxidant activity of complex natural mixtures, and makes 
it possible to identify specific ingredients/compounds with antioxidant activity which 
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Abbreviations and Acronyms 
Abbreviation  Full term 
(+) ESI  ESI operating in positive ion mode 
[M + H]+  Molecular plus H ion 
[M – H]-  Molecular minus H ion 
[M]+  Molecular ion 
AR  Analytical reagent 
CVD  Cardiovascular Disease 
DPPH  2,2-diphenyl-1-picrylhydrazyl 
EC  Epicatechin 
ECG  Epicatechin gallate 
EGC  Epigallocatechin 
EGCG  Epigallocatechin gallate 
Caf  Caffiene 
Thea  Theanine 
Theo  Theobromine 
ELSD  Evaporative Light Scattering Detection 
ESI  Electrospray ionisation 
EtOH  Ethanol 
FRAP  Ferric reducing ability of plasma 
F-C  Folin-Ciocalteu 
GA  Gallic Acid 
GC  Gallocatechin 
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g  Gravitational acceleration 
h  Hour 
HPLC  High performance liquid chromatography 
I.D.  Internal Diameter 
LPS  Lipopolysaccharide 
m/z  Mass-to-charge ratio 
Max.  Maximum 
MeOH  Methanol 
min  Minute 
Min.  Minimum 
MS  Mass spectrometer 
RP-HPLC  Reverse-Phase High Performance Liquid 
Chromatography 
TGA  Therapeutic Goods Administration 
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Chapter 1: Introduction 
 
 
Herbal medicines have been used to treat a variety of chronic diseases with reduced 
side effects. Many individuals suffer adverse effects of Western pharmaceuticals or 
mistrust and therefore herbal medicines are a viable option for many. However, 
many factors affect the chemical composition of the herbs and inconsistencies in the 
final herbal products have been widely observed. Consistency concerns with herbal 
medicines must be resolved before they can be accepted as safe and reproducibly 
effective. Herbal products are complex, typically containing hundreds of compounds. 
It is difficult to monitor all these compounds in routine quality control. It is also 
often unclear which of the components are biologically active and responsible for the 
herbs activity. To simplify the quality assessment of herbs major compounds are 
selected as markers of quality.  
 
1.1 Marker compounds and quality control of Complementary Medicines 
 
 
Complementary medicines often have a complex chemical composition, and in many 
cases the nature of so called “active” compounds in those products are not known. 
Thus, in order to compare their chemical similarity and efficacy, the assessment of 
certain chemical markers is used as a measure for quality control. Marker compounds 
often include those molecules that are present in reasonable quantities in the product, 
and link to the action or efficacy of the products. The usual criteria that a suitable 
marker compound for complementary medicines needs to fulfil are that is present in 
the mixture in high abundance and that there is a significant proven benefit to the 
disease of interest(1). In some cases, however, the link of the marker compounds to 
the product efficacy has not been established. Thus, it is important to establish if the 
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markers compounds are suitable and capture the activity of the products to be 
compared as proper marker compounds can provide a basis to rank the quality of 
natural products(2). 
 
The Therapeutic Goods Administration (TGA) is the governing regulation body that 
oversees medicines and supplements in Australia and provides guidelines for 
manufacturers to adhere to in order to be able to sell their product. Currently, 
manufacturers only need to quantify marker compounds that are on the label as an 
active. This leaves the door open for less specific claims. For example, claims such as 
“14x extract” can be made based on the production extraction without the extract being 
containing 14 times the concentration of the chemical components in the raw material. 
Product claims of this type are not subject to regulated quantitative testing and are 
therefore open to exploitation. Cost saving practice of re-extraction or extraction of 
diluted materials are purported to occur within the industry.  This can result in 
misleading and low quality finished products.  The chemical composition of the herbal 
marker can be used to access this; however, natural variations will exist. To determine 





Given natural variation, it is extremely unlikely that any 2 herbs will be identified as 
chemically exactly the same- there will always be minor variation. Based on chemical 
abundance alone it is difficult to predict how minor variations in the chemical 
composition affect the biological activity. It is therefore crucial that for any 2 herbs to 
be considered equivalent they must have equivalent chemical composition and 
biological activity; this is termed phytoequivalence. Bioequivalence is a term used in 
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pharmacokinetics that describes two pharmaceutical products that are biologically 
equivalent, meaning, that the same dose of each of the two products will exhibit the 
same pharmacological effect(3). Similarly, this is described in natural products as 
phytoequivalence. This comes from a recognition that there is no way to 
comprehensively determine what the components of the herbs do when consumed. As 
a result, it is difficult to determine which of the components are responsible for the 
biological activity (or modulating the biological activity), and therefore all compounds 
need to be monitored to maintain pharmacological consistency. To ensure that there is 
a level of consistency, there needs to be a matching phytochemical composition and 
biological activity. 
Marker compounds can be quantified to account for some of the activity of a product 
to allow for product comparison. The question that must be answered is, do these 
marker compounds capture the activity of the herb, if the answer is yes, then it is a 
suitable marker compound to determine the quality of similar herbal products.  Marker 
compounds can provide a basis to rank the quality of natural products. The usual 
criteria that a suitable marker compound needs to fulfil are that is present in the mixture 
in high abundance and that there is a significant proven benefit to the disease of 
interest(1). 
 
1.2 Green tea   
 
1.2.1 Traditional use 
 
Green tea has been used for centuries as a medicine to treat a variety of diseases. One 
of the earliest mentions of green tea is taught in Chinese mythology, where in 2737 
B.C.E, the emperor Shen Nung first discovered the medicinal properties of tea. Until 
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the ‘Tang dynasty in 618-906 C.E(4), tea was only considered as a medicine, but soon 
after became popular as a beverage. Throughout this era it is recalled that tea was 
consumed in vegetable soups with various other ingredients such as ginger and orange 
peel. A method of brewing used by ancient Himalayans is brick tea, this is still a 
popular brewing method in modern Mongolia. During the “Song” dynasty (10th-13th 
centuries), this method became less widespread and was replaced by a powered form 
of tea that was whipped into froth. This form of tea is a bright emerald green colour 
with lower astringency than normal tea. This preparation method of tea survives today 
in Japan as Mattcha(5). The medicinal properties of green tea were also recorded in 
the pharmacopeia, “Ben Cao Gang Mo”, written by Shi Zheng Li in the Ming dynasty 
(16th century)(6). The use of tea has continued into the modern era. 
 
1.2.2 Modern use 
 
Tea is one of the most widely consumed beverages in the world, second only to 
water(7). In the USA alone 320g of tea (equivalent to 35-40 L) are consumed per 
capita. In India, this number is almost doubled, and Ireland consumes this amount ten-
fold(4).  It is made from the leaves of Camellia Sinensis, an evergreen plant, native to 
China and many other Asian countries (Fig. 1). There are two major varieties of the 
plant, the Sinensis variety, popular in China, Japan and other parts of Eastern Asia, and 
the Assam variety is more popular in tropical regions such as India. These plants are 
characterized by their larger leaf size, up to 20cm compared to 5 to 12 cm of the 
Camellia Sinensis leaves(4,8). In most cases, the Sinensis variety is used for the 
preparation of green teas and the Assam variety is used in the production of black 
teas(9). There are various types of green tea products, such as oolong, green and black 
teas which are related to the different extraction /manufacture process involving 
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withering, bruising, fermentation and drying (see Fig 2). It is estimated that about 78% 
of the tea production is black tea, followed by green tea (20%) and other types of teas.s 
There is an extensive history of green tea intake by humans, its medicinal use dates 
back thousands of years and continues in modern times. 
 
1.3 Health benefits of green tea 
 
 
The health benefits of green tea have had a growing interest in the last few decades. 
The annual sales of dietary supplements globally in 2013 was $67 billion, according 
to a publication in the JAMA Internal medicine(10). The article also concluded that 
this usage was not limited to a particular age group or gender, therefore its popularity 
is widespread.  
Green teas use as a supplement may be based on traditional uses however there are 
recent studies that support the use of green tea as a supplement. There have been 
various studies on the potential health benefits of green tea, such as; anticancer(11), 
cardioprotective(12), neuroprotective, , anti-diabetic, antimicrobial, anti-viral and 
anti-inflammatory effects(13). Most effects are thought to be related to the antioxidant 
properties of chemical ingredients in the green tea mainly polyphenols, especially 
catechins such as epigallocatechin gallate (EGCG)(14).  These polyphenols are present 
in all forms of tea, however they are present in much higher concentrations in green 
and white teas then they are in black teas, thus green tea is the preferred source of 
antioxidants.  
 
The major health benefit of green tea is its antioxidant activity(14). An antioxidant is 
a compound that is able to prevent or slow down the oxidation of another 
compound(15). Antioxidant activity is complex; there are many antioxidants that act 
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by different mechanisms on different oxidative agents. Oxidation can be caused by 
free radicals. Antioxidant activity may be assessed by the DPPH (2,2-di-phenyl-
picrylhydrazyl) assay(16,17), and the Folin-Ciocalteu assay(18).  The DPPH reagent 
is a radical compound with a strong absorbance at 515nm. Hydrogen-donating 
antioxidants reduce the DPPH free radical, therefore lowering the absorbance reading 
at 515nm and visualised as a colour changed from deep purple to yellow. FC assay is 
a colorimetric method that uses a mixture of phosphomolybdate and phosphotungstate, 
that shows a colour change from blue to yellow when it is reduced. 
Some of the most exciting research that has been done on tea is benefits toward cancer 
research. There have been clinical trials that has been undertaken on the contribution 




Cancer is a common disease affecting a larger proportion of the global population(11). 
According to statistics by the Australian Cancer Council, 1 in 2 Australians will be 
diagnosed with cancer by the age of 85, and this year it is estimated that there will be 
138,000 new cases of cancer diagnosed, with this number set to rise to 150,000 by 
2020. In 2014 cancer was the second leading cause of death in Australia, accounting 
for about three in every 10 deaths. This has risen since then and this year is expected 
to end with 48,000 cancer related deaths(19). Green tea has been used to prevent and 
treat a variety of cancers including breast, liver and prostate cancers. In a Canadian 
report by Boon et. al. (2007) green tea was the most commonly used for “self-
treatment” of breast cancer(20). According to Yang (1993) the main reason for this is 
the that polyphenols inhibit cancer cell proliferation(21). However, there has been 
limited evidence to suggest that there is a significant causal link between the 
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consumption of green tea and a lower incidence of cancer. A review by the 
International Agency for Research on Cancer Working Group(22), determined that 
there was not enough clinical evidence to suggest the tea drinking could lower the 
carcinogenicity in humans and animals. There have however been significant advances 
for in vitro studies(21).   
 
Despite widespread use the efficacy and mechanism for green teas against cancer is 
yet to be established. Green tea is used and has shown some promise in the treatment 
of other diseases.  
 
 
1.3.2 Cardiovascular diseases 
 
 
Cardiovascular diseases (CVD) are a major burden on the healthcare sector 
worldwide(7). According to the World Health Organisation (WHO 2011), almost one 
third of the total global deaths can be attributed to CVD. A variety of studies have led 
to a conclusion that the consumption of green tea can have a positive effect on 
cardiovascular function. One of the major contributors of cardiovascular disease is 
atherosclerosis, CVD can be caused when the arteries become blocked. When the 
arteries become blocked by a blood clot or when the blood flow is restricted, this limits 
how much blood and oxygen can be delivered to the organs or tissue. Based on a 
literature review (14,28,29), compounds in green tea such as theobromine have been 
found to have cardiotonic properties. This could indicate why green tea has been 




1.3.3 Cognitive Function 
 
 
In addition to these theobromine and polyphenols, green tea also contains the amino 
acid, L-theanine that is unique to tea(8). L-theanine also has the potential to cross the 
blood-brain barrier (BBB)(8,30). It has been shown to have a calming effect on the 
brain and negating the effect of caffeine. This effect has been suggested through very 
limited pharmacological studies on the effect of the caffeine from tea as opposed to a 
regular dose of caffeine and observing the different effects. 
One significant study on the pharmacological effect of L-theanine monitored the anti-
stress effect on mice after consuming Gyokoru, a variety of tea that is rich in the amino 
acid L-theanine. The effect was compared with standard sencha tea and sencha tea 
with lowered caffeine(30). The study showed adrenal hypertrophy was significant 
lowered in the mice that ingested theanine. This dosage (0.32mg/kg) was much lower 
than the theanine in standard sencha tea (5mg/kg), which suggested that there was a 
component of the tea that had a suppressive effect on the anti stress effect of theanine. 
There have been previous studies that have found that caffeine antagonizes 
theanine(31). Although there were also findings by Unno et al that suggested that 
ECGC also suppressed the action of theanine(30). 
 
Further studies of L-theanine have found that this amino acid present in green tea can 
improve cognitive impairment in mice that have been injected with Aβ peptides(32). 
In this study, the mice were treated these peptides which induced cell neuron death. 
The study found that the treatment of L-theanine was able to repair the cognitive 
damaged caused by the Aβ peptide treatment and therefore improve the cognitive 
health of the mice. 
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Green tea and it components have been shown to have a variety of beneficial effect on 
health, it is therefore not surprising that green tea is widely used to improve health.  
 
1.3.4 Weight loss 
 
 
Obesity is a growing health concern in the global population and a priority for a lot of 
prevention and early intervention healthcare strategies. Obesity has been defined by 
the World Health Organisation (WHO) as “abnormal or excessive fat accumulation 
that may impair health”(23). The clearest way to determine whether or not someone is 
overweight or obese is by their body mass index (BMI). An adult with a BMI of 25 
kg/m2 is classified as overweight. An adult with a BMI of 30kg/m2 or higher is 
classified to be obese. The average BMI differs among different countries. For 
example the average BMI in some Asian countries is often lower(24). 
 
Tea, high in bioactive flavonoids, has been found to assist with weight loss,(25). Green 
tea has been found to have a history of uses in the management of weight and has been 
observed and claimed in some cases since the early 1990s, to increase the energy 
output of some individuals, thus stimulating weight loss. Research by Dullo, A.G et 
al. suggests that the combined activity of the polyphenol EGCG and caffeine has a 
more profound effect on weight loss than the caffeine alone(26). In this study, the 
subjects were treated with one of three dosages; a mixture of 50mg of caffeine and 
90mg of EGCG, 50mg of caffeine, as well as a placebo. The subjects were tested on 
three occasions over a 24 h period for their respiratory quotient and urinary excretion 
of nitrogen and catecholamines in 10 healthy men. On three randomly selected 
occasions, the test subjects were assigned to 3 different treatments as described above. 
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The study found significant metabolic differences between the groups treated with 
caffeine and caffeine/ECGC combo, compared to the placebo. 
Green tea weight loss supplements reportedly contain a higher concentration of 
catechins, thus increasing the potency of the antioxidants in comparison to the tea leaf 
products(26). However there have been various toxicological studies on green tea 
weight loss supplements that have been linked to various cases of liver damage as well 
as heart problems, such as acute left ventricle(27). It is unclear whether these effects 
are due to high catechin content or other components, as they are typically poorly 
characterised.  
In contradiction to these safety concerns green tea has been suggested to be beneficial 
in the treatment of cardiovascular problems.  
 
1.4 Safety of green tea supplements 
 
Most green tea dietary supplements are “listed medicines” by the Therapeutic Goods 
Administration (TGA). Listed medications are slight different from registered 
medications in that the products that are of lower risk to the consumer than registered 
medicines and are usually for a consumer’s self-medication. In Australia, TGA-listed 
medications are labelled with an “Aust-L” number and TGA-registered products are 
labelled “Aust-R”. Listed medicines will only contain ingredients that have been well 
established and have a long history of use or the condition.  
 
Various report suggests that high doses of EGCG can lead to hepatotoxicity(33). These 
reports may be linked to other contaminates in the products as in highly regulated 
markets this toxicity has not been observed. The TGA monitor the adverse events 
reported for green tea products sold in Australia. There are over 267 products the vast 
majority have been available and sold for years. While international concern of liver 
23 
 
harm are noted by the TGA no concerns have been recorded for product sold and 
monitored in Australia(34). The safety and benefits of the green tea products are linked 
to their chemical composition. 
 
1.5 Chemical profile of green tea  
 
 
The major components of green tea are its flavonoids and poly phenols, of which make 
up 50 to 60% of the dry weight of the tea leaves(8,35). The five major classes of 
polyphenols include phenolic acids, stilbenes, flavonoids, lignans, tannins and flavan-
3-ols(8).  Catechins are the major flavanols in green tea, namely, epicatechin, 
epigallocatechin, epicatechin gallate and epigallocatechin gallate(2). 
Figure 1 illustrates the main polyphenols in green tea and their chemical structure. The 
major catechins in green tea: epicatechin (EC), epicatechin gallate (ECG), 
epigallocatechin (EGC) and epigallocatechin gallate (EGCG).  
 
 












Catechin and epicatechin both are monomeric flavanol, epicatechin has an ortho-
dihydroxyl group in the B-ring at carbons 3' and 4' and a hydroxyl group at carbon 3' 
on the C-ring. EGC has trihydroxyl group at carbons 3', 4', and 5' on the B-ring. ECG 
has gallate moiety esterified at carbon 3 of the C-ring. However, EGCG has both 
trihydroxyl groups at carbons 3', 4', and 5' on the B-ring and a gallate moiety esterified 
at carbon 3' on the C-ring(36) on the chemical backbone of flavonoids(37). These 
catechins account 30-42% of the dry weight of green tea and EGCG the main catechins 
accounts 50-80% of the total catechins (35). It was reported that radical-scavenging 
ability of EGCG was higher than that of other catechins due to the presence of a gallate 
moiety in the C ring(38). Catechins are ordered based on their antioxidant activity as 
indicated by a number of studies: EGC ~ EGCG >> ECG = EC > catechins and the 
number of hydroxyl groups is the major factor contributing to antioxidant potential of 
catechins of green tea(39,40). 
There are five major types of flavan-3-ols in green tea, including catechin, epicatechin, 
epicatechin gallate, epigallocatechin, and epigallocatechin gallate (EGCG). Table 1 
shows an outline of the composition of the main polyphenols in green tea.  
 


















Tea comes from different variations of the evergreen shrub known as Camellia Sinesis. 
There is a large amount of variation in the chemical constituents, particularly between 
green and black tea. These arise from variations in the climate, the harvesting and the 
variety of the tea. 
The variety of the tea that contains the highest concentration of catechins is white tea. 
This tea is prepared by harvesting the young leaves or buds from the tip of the plant 
and the leaves are blanched and dried as very quickly in order to stop the oxidation 
process. Green tea leaves are still for the most part un-oxidised although the more 
mature leaves are picked from plant, therefore the polyphenol content is not as high as 
that of white tea. 
Black tea is the fully oxidised form of tea, the leaves are withered and rolled to allow 
the fermentation process to take place(8,41). This process produces a by-product, 
theaflavins and thearubigens. Because of this, the antioxidant effect of black tea is 






Figure 2: Schematic of the tea extraction processes. Adopted from Cooper R (2005) 
Medicinal Benefits of Green Tea: Part 1. Review of Noncancer Health Benefits(7). 
 
 
The oxidation (or fermentation) process is catalysed by the enzyme phenol oxidase(8). 
After this process of fermentation, the content of polyphenols, the main antioxidants 
in tea, are reduced and the molecules known as theaflavins and thearubigens. 
According to a review by Harbowy and Balentine(41), green tea contains on average 
3 times the catechin content of black tea. Differences in the fermentation process can 
influence the chemical composition of the tea.  
 
It has been demonstrated that different processes in the green tea production affect the 
chemical compositions of green tea products. For example, unfermented green tea 
contains the highest concentration of flavan-3-ols. During tea fermentation, flavan-3-
ols undergo polyphenol oxidase-dependent oxidative polymerisation, resulting in the 
formation of theaflavins and thearubigins(42). Oolong tea is a partially fermented 
product and therefore contains a mixture of flavan-3-ols, theaflavins, and thearubigins. 
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Black tea is the most fermented tea, and as a result, contains abundant theaflavins and 
thearubigins, and limited or no flavan-3-ols(43). 
 
A study on the effect of the levels of these bioactives in green tea by Lee, L et al, has 
discovered that over a two (2) month plucking period, the contents in tea of 
epicatechin, epigallocatechin gallate, and epigallocatechin significantly increased, 
whereas the contents of catechin, gallocatechin gallate, theanine, theobromine and 
caffeine were decreased significantly(44). The antioxidant activity, determined by 
ABTS, FRAP and DPPH assays showed an increase in the total antioxidant content 
with the increased age of the harvested leaves. To address the factors effecting the 
consistency of green tea marker compounds are used. 
 
1.7 Selection of green tea marker compounds 
 
Marker compounds are selected to reflect the quality of a herbal extract without 
quantifying all chemicals present. There are a variety of way marker compounds are 
selected, it can be based on convenient factors availability of commercial reference 
standards or abundance. It is ideal to have markers that are not necessarily based on 
convenience but reflect the activity of the herb. Selection of marker compounds should 
be based on pharmacological activity(1). These selection criteria are primarily 
designed to determine the quality of complex herbal formulas, although can be applied 
to many complex herbal materials such as green tea. The purpose of these criteria is to 
consider the components of a herbal mixture and to determine how likely each 
component is to be a major contributor to the activity of the herb. A number of factors 
should be considered; 
 The Traditional use of the herb 
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 Relationship between the action and disease of interest 
 The bioavailability of the compounds 
 The quality of the research conducted 
 The amount of research to support the action of the compound 
 Toxicity of the compound and safety limits applied to its use 
 Physical and chemical properties of the compound 
 The part of the plant used in the product and the relative concentration of each 
analyte present 
The constituent needs to demonstrated bioactivity (in vitro/in vivo), this is difficult and 
sometime unachievable for more complex formulas, making it difficult to determine 
the active compound. 
 
The marker compounds can be ranked on a scale from 1, being the lower end, and 5 
being upper end. For an analyte to have a rank of 5, the first thing that needs to be 
investigated is the concentration of the analyte in the sample. The compound should 
be abundant in the herb to have a larger effect. For example, a compound that is present 
at 2000ppm is more likely to be more active than a compound that is present at 
concentrations <1ppm, although other factors also play into its activity. This carries 
onto the next criterion, that the compound should have an activity that is related to the 
disease or condition of interest. The activity that has been proven in the literature 
should be related to the disease of interest, as well as the traditional or current use of 
the herb being used for this same or similar purpose. Green tea, as described in section 
1.2, has in the past been linked to various health benefits that help a variety of health 
conditions and more recently there has been work done on the mechanism of action of 





1.8 Aims and objectives of the study  
 
 
There are three main aims of the study. The first of which is to determine the contents 
of marker compounds of green tea products/batches to assess the quality of these 
products. 
The second aim is to determine the phytoequivalence of various green tea extracts/ 
products, the chemical equivalence in terms of the marker compounds and the 
pharmacological equivalence in terms of the antioxidant activity. 
The third aim is to develop an online assay to identify the compounds responsible for 
the antioxidant activity of various ingredients in green tea extracts/products. 
In order to achieve these objectives, ten different samples of tea will be selected from 
the available market.  
    
The objectives of this study are to 
1. Develop a suitable method to assess the phytochemical variation between the 
different batches of Green tea products; 
2. Utilise chemo metric data analysis to identify any correlations in chemistry 
between the products; 
3. Develop activity-based assays to assess the pharmacological variations between 









2.1.1 Reagents and Primary Standards 
 
 
The primary standards; gallic acid, caffeine, epicatechin gallate, epigallocatechin 
gallate and theobromine were of analytical standard grade and purchased with a 
certificate of analysis from Sigma Aldrich (Castle Hill, New South Wales, Australia). 
The primary standards gallocatechin, epigallocatechin and epicatechin were of 
analytical standard grade and purchased with a certificate of analysis purchased from 
Biopurify Phytochemcials Ltd (Chengdu, Sichuan, China). 
The Folin Ciocalteu (FC) reagent used in the total phenolics bulk assay was sourced 
from Sigma Aldrich (USA). The DPPH reagent used in the bulk antioxidants assay 




The test samples are shown in Table 2. Tea leaf samples were purchased off the shelf 
from a local shopping centre.  The powdered matcha tea and TGA listed (Aust-L) 









Table 2: Sample information 
Code Type Label claim ingredient Expiry* 
S1 Tea Powder ECGC, Catechins 09/03/19 
S2 Tea Power No specific claims 31/1/18 
S3 Tea leaves No specific claims 10/7/2020 
S4 Tea leaves No specific claims 01/02/2020 
 
S5 Tea leaves No specific claims 23/06/2019 
S6 Tea leaves No specific claims 29/7/18 
S7 Tea leaves Caffeine 
 
20/8/2020 
S8 Tablet ECGC, catechins 01/01/2018 
S9 Tablet  ECGC 
 
01/10/2019 
S10 Sachet tea powder  1 sachet tea equivalent 01/08/2018 
S11 Tablet Catechin, incl EGCG 01/12/2018 
S12 Tablet No details. No details. 






















2.2.1 HPLC Instrumentation: 
 
HPLC analysis was performed on a Shimadzu LC 30AD (Rydalmere, NSW, 
Australia), with a photo-diode array detector (Shimadzu SPD-M20A) and operated 
using Shimadzu Lab Solutions software. The chromatographic column used was a 
Phenomenex Luna C-18 (150 x 4.6 mm with  3 µm particle size). 
 
Figure 3: The HPLC system in the NICM Herbal Analysis Laboratory located at Western 













2.2.2 HPLC-ESI-MS-MS Analysis 
 
 
LC-MS analysis was performed using a Waters Xevo TQ with electrospray ionisation 
(ESI) source and Waters Acquity UPLC.  A Waters Acquity PDA detector was 
connected in parallel to the MS detector.  Separation was achieved on an Acquity 
UPLC BEH C18 (2.1 x 50mm with 1.7µm particle size) column. Data was analysed 
using MassLynx/Targetlynx version 4.1, SCN876. 
 
2.2.3 HPLC and Post Column Antioxidant Screening Analysis 
 
 
The online antioxidant screening was performed on a Shimadzu HPLC system, 
equipped with a Shimadzu SCL-10A controller, SIL-10AD auto injector, LC-20AD 
pump, FCV-10AL switching valve, a SPD-M10A PDA detector and a Phenomenex 
(Lane Cove, NSW, Australia) DG-4400 degasser. One Shimadzu LC10AD pump, 
fitted with an inline degassing unit (Phenomenex DG-4400 (Lane Cove, NSW, 
Australia)) was used to deliver the post-column derivatisation reagent. An additional 
Shimadzu LC-10AT pump was used for the addition of the FRAP reagent post column. 
A splitter system was used to simultaneously direct eluent to the PDA and fluorescence 
detectors (FLD) in one HPLC run. The detectors acquired data in parallel, with the 
split set to divert 0.5 mL/min to the PDA and 0.5 mL/min to the FLD from the 1.0 
mL/min column flow rate.  A Hypersil GOLD column (150 × 4.6 mm, particle 
diameter 5 µm) from Thermo Fisher Scientific (Runcorn, Cheshire, United 
Kingdom).was used for the reaction flow analysis(45).  A schematic diagram of the 




Figure 4: This is an illustration of the instrumental setup of the online system. 
 
 
2.2.4 Miscellaneous Equipment 
 
 
The extracts and chemical reagents were weighed using an Adam (Australia) AFA-
210 HPLC analytical balance when the mass being weighed was >100 mg. The 
standards, extracts and some reagents were weighed using a Sartorius (Germany) SE2 
ultra-micro-balance when the mass being weighted was <100 mg. 
 
 The ultrasonic water bath that was involved in the extraction of the samples was a 
Power Sonic 420 from Thermoline Scientific (Australia). The purified water used in 
analysis was prepared using a Milli-Q Direct 8/16 Water Purification System. Filtered 
using a 0.22µ Millipore filter. The automatic pipettors P100 (10 – 100 µL) and P1000 
(100 – 1000 µL) series 2100 were from Eppendorf (Germany). The multi-channel 
pipettor Finnpipette (1 – 10 µL) was from Thermo Scientific (USA). Volumetric 
pipettes and volumetric flasks used were class A specification purchased from Duran 
(Germany). The plate reader used for the antioxidant assays was a FLUROstar 







2.3.1 Selection of marker compounds 
 
The compounds selected as potential chemical markers for green tea quality were 




The concentration of the marker compounds in the samples was quantified by HPLC. 
A standard stock solution was prepared by accurately weighing 1g of each standard 
and dissolving in 10 mL of 50% aqueous methanol. The samples were extracted in two 
different extraction solvents and were tested based on the determined optimum 
extraction solvent (50% aqueous methanol) as well as water extracts to mimic 
cosmopolitan tea drinking. 
The water extracts were prepared by grinding the tea leaves (unless already powdered) 
using a herb grinder and accurately weighing out 1 gram of the powder. The powder 
was then dissolved in boiling water and cooled before then filtering the resulting 
concoction. 
The aqueous methanoic extracts were prepared by dissolving 1 gram of the powdered 
product in 50% aqueous methanol and then ultrasonicating for 30 minutes at room 
temperature. 
The flow rate was set at 1.00 mL/min with a gradient mobile phase consisting of 
aqueous formic acid (0.4 % v/v): Methanol. The injection volume of each sample and 






Table 3: Mobile phase program used for the HPLC quantification of Green teas. 
Time 
(min) 




Solvent A  
(%) a 
  
Solvent B  
(%) b 
Initial  Analysis  1.00  95  5 
30  Analysis  1.00  0  100 
34  Wash  1.00  0  100 
34.1  Equilibration  1.00  95  5 
37.1  Equilibration  1.00  95  5 
a 0.4% v/v aqueous formic acid; b Methanol. 
 
The λ det of the marker compounds used was 270 nm. This wavelength appeared to 
give the best compromise between sensitivity of detection and the baseline noise. The 
column temperature was maintained at 30 oC under the specified chromatographic 
conditions to yield back pressures between 2300 - 2700 psi.  
 
 
2.3.3 HPLC-ESI-MS/MS Analysis 
 
The concentration of L-theanine in the samples was quantified by LC-MS. The 
samples and standards prepared for the HPLC analysis (2.3.1) were analysed by LC-







Table 4: HPLC and MS conditions for the quantitation of green tea 
Time 
(min) 




Solvent A  
(%) a 
  
Solvent B  
(%) b 
Initial  Analysis  0.6  95  5 
 0.5  Analysis  0.6  95  5 
2  Analysis  0.6  50  50 
2.1  Wash  0.6  0  100 
4.0  Equilibration  0.6  95  5 
5.0  Equilibration  0.6  95  5 
a 0.4% v/v aqueous formic acid; b Methanol. 
 
The for the MS analysis, a targeted analytical run was performed. The direct infusions 
of the pure standards were performed and optimum precursor and product ions were 
































Theobromine 180.164 181.13 36 137.85 18 ES+ 
181.13 36 163.04 18 ES+ 
181.13 36 67.01 28 ES+ 
Gallic Acid 170.12 169.09 30 124.9 14 ES- 
169.09 30 78.34 20 ES- 
169.09 30 78.92 24 ES- 
EGCG 458.37 459.15 74 139.00 18 ES+ 
457.15 96 168.94 20 ES- 
459.15 74 289.03 8 ES+ 
EC 290.27 291.17 28 139.00 16 ES+ 
291.17 28 122.99 14 ES+ 
291.17 28 165.0 12 ES+ 
Caffeine 194.194 195.16 40 138.03 20 ES+ 
195.16 40 110.04 22 ES+ 
195.16 40 42.06 30 ES+ 
Theanine 174.2 175.23 20 84.01 18 ES+ 
175.23 20 158.04 12 ES+ 
175.23 20 46.04 12 ES+ 
ECG 442.37 441.15 38 168.94 18 ES- 
443.15 22 122.99 14 ES+ 
441.15 387 289.04 16 ES- 
EGC 306.27 307.17 20 139.01 14 ES+ 
305.17 38 124.95 24 ES- 
305.17 38 178.97 16 ES- 
GC 306.27 307.17 26 139.01 14 ES+ 
305.11 36 124.95 26 ES- 
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307.17 26 150.98 10 ES+ 
 
 
2.3.3 Antioxidant assays 
 
2.3.3.1 Total Phenolics Assay 
 
 
The total phenolic content of the tea samples was determined using the Folin Ciocalteu 
(FC) method. The samples were prepared the same way as in section 2.3.1. These 
concoctions were then diluted 1 in 10 in a 2mL Eppendorf tube. 2.573 mg of the gallic 
acid standard was dissolved in 10mL of methanol to make a 1.5mM stock solution. 
The sodium carbonate buffer (0.7M) was prepared by dissolving 752mg of sodium 
carbonate in 10ml of Milli-Q water. The stock solution was used to make gallic acid 
standards 1.5, 1.2, 0.9, 0.6, 0.3mM by serial dilutions. 20µL of the standards, samples 
and blank were pipetted onto a 96-well micro plate along with 140µL of water and 
20µL of F-C reagent. The contents were vortexed before the reaction was ceased by 
adding 30µL of sodium carbonate solution to give the well a final volume of 200µL. 
The plate was shaken at 37oC for 30 mins in the dark before the absorbance was 
measured at 765nm using POLARstar OPTIMA, BMG. The values were expressed as 
milligram gallic acid equivalents per gram of dried extract (mg GAE/g DE). 
 
 
2.3.3.1 DPPH Radical Scavenging Assay 
 
The DPPH radical scavenging capacities of the tea samples were determined by a 
method adapted from Blois et al. and Molyneux et al(16,46). All samples and reagents 
were prepared in methanol. The gallic acid calibration curve was obtained by preparing 
0.3, 0.6, 0.9, 1.2 and 1.5 mM working standards, by diluting the 1.5mM stock solution. 
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Samples were prepared the same way as for the HPLC analysis, 2g of sample in 200 
mL. Dilutions 1:10 of the stock tea sample solutions and 1:100 of the stock G.T.E 
tablets were also prepared. Water was used as the reagent blank. DPPH reagent (250 
μM; 180 μL) and 20 μL of sample, standard or blank were applied to each well of a 96 
well microtitre plate to give a final volume of 200 μL. The plate was shaken for 30 
min in the dark prior to measuring the absorbance at 515 nm (POLARstar OPTIMA, 
BMG). All values were expressed as milligram gallic acid equivalents per gram of 
dried extract (mg GAE/ g DE). All data was expressed as the mean ± standard error of 
the mean of three independent experiments performed in triplicates. 
 
2.3.4: Online FRAP:  
 
The FRAP reagent was adapted from the work performed by Benzie and Strain(47). 
The acetate buffer (300mM, pH 3.6) was prepared by dissolving 40.8g of sodium 
acetate trihydrate in 500mL of Milli-Q water with the aid of ultrasonic agitation. The 
pH of the solution was then adjusted to 3.6 (±0.1) with glacial acetic acid and diluted 
to 1L with Milli-Q water. HCl (40mM) was prepared by diluting 3.3 mL of the 
concentrated hydrochloric acid to 1L milli-Q water. TPTZ (10mM) was prepared by 
by dispersing 62.5 mg TPTZ in 20 mL of 40 mM HCl with the aid of ultrasonic 
agitation. Ferric chloride (20 mM) was prepared by dissolving 108.1 mg ferric chloride 
hexahydrate in 20 mL of Milli-Q water with the aid of ultrasonic agitation. The final 
FRAP reagent was prepared by combining 500 mL of 300 mM acetic acid buffer pH 
3.6, 20 mL of 10 mM TPTZ and 20 mL of 20 mM ferric chloride. The derivatisation 
reagent FRAP, was prepared daily and filtered through a 0.22 µm filter before use(48). 





Table 6: HPLC conditions for the online antioxidant assay 
Time 
(min) 




Solvent A  
(%) a 
  
Solvent B  
(%) b 
Initial  Analysis  1.0  95  5 
30  Analysis  1.0  0  100 
34  Wash  1.0  0  100 
34.1  Equilibration  1.0  95  5 
38.6  Equilibration  1.0  95  5 




Chapter 3: Results and Discussion: 
 
3.1 Ranking of marker compounds 
 
The marker compounds were selected based on the on pharmacological activity, 
commercial availability and abundance (Bensoussan et al., 2015). Table 7 lists the 
potential marker compounds that, based on the literature, describe the quality of green 


























Action Ranking Commercially 
Available 
















































Caffiene 3810.0 – 93000 Antiobesity, CNS 
stimulant, antioxidant, 
diuretic, Vasodilator,  
5 Yes 
















3.2 HPLC Profile of Green Tea products 
 
To access the quality of the tea samples a HPLC method was developed that adequately 
separate marker compounds. The marker compounds, including gallic acid, 
gallocatechin, theobromine, epigallocatechin, epigallocatechin gallate, caffeine, 
Epcatechin and epicatechin gallate, were studied. A representative chromatogram of a 




Figure 5:  HPLC chromatogram of chemical markers: gallic acid (1), gallocatechin (2), 
theobromine (3), epigallocatechin (4), epigallocatechin gallate (5), caffeine (6), 
epicatechin (7) and epicatechin gallate (8). The HPLC condition for determination of 




As shown in the Figure, all marker compounds were efficiently separated under the 
experimental condition, indicating that the HPLC method used in this study is adequate 
for the proposed research aims. The determination of catechins by HPLC in green tea 
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products was previously validated by Naldi et al  and shown to be sensitive and 
accurate(50).  
 
To determine the appropriate wavelength to use for analysis of marker content in green 
tea products, the heat map of a green tea exact (S4) was obtained (Figure 6).  It 
illustrates that the absorbance of various compounds was wavelength-dependent. The 
wavelength selected for this analysis was 270nm. This wavelength is also commonly 
used in the literature for the examination of green tea. The reason for this is that the 
lambda (λ) maxima for all of the selected compounds is within this range. This is 
shown in figure 7, where the pure standard of the marker compound (pink) is overlayed 
with the corresponding peak in the tea sample (black). The graphs below also show a 
peak at around 230nm as well as some methods in the literature. While this still would 
be an optimum wavelength for the compounds with a lower peak intensity at 270nm, 
it can be shown on the heat map in figure 6 that there is significant baseline interference 








The heat map in Figure 6 confirm the ideal wavelength of 270nm that is commonly 
reported is appropriate. There are some compounds that did not absorb as efficiently, 
however, the chosen wavelength gave the best representation with minimum 
interference from the baseline noise. 
 
Figure 7: comparison of HPLC chromatogram of green tea extract (sample 4, A) and 
marker compounds (B). The number 1-8 indicate the relevant peak for marker 
compounds. I-VIII  show UV UV spectrums for Epicatechin (I), Epicatechin gallate 
(II), Epigallocatechin (I) 
3.2 HPLC profile of tea samples 
 
 
Using the established HPLC method, the HPLC profiles of various green tea product 
samples were studied, including two matcha products (S1, S2), five traditional tea leaf 
products/tea bag (S4,S5,S6,S7), tea sachet supplement (S10) and three TGA listed 
tablets (S8,S9,S11). These products were sourced locally. The identity of manufacturer 
of each product was recorded but not revealed in this thesis. Due to this study’s time 
limit, these samples are only a representative of a large number of green tea products 
on the market. It is not our intention to include all commercial green tea products in 
this study. Nevertheless, the list covers several main types of green tea products, 
including traditional tea leaves/bags, tea power, tea extracts-derived products (tablets 
and sachet) as TGA listed complementary medicines. The representative HPLC 






Figure 8: Representative HPLC chromatogram of green tea products. Samples include 






























































Figure 9: Representative HPLC chromatogram of green tea products. Samples include 


























































Figure 10: Representative HPLC chromatogram of green tea products. Sample 8-10, 
including TGA listed tablets (S8,S9,) and sachet (S10). The HPLC condition for 



































































Figure 11: Representative HPLC chromatogram of green tea products. Sample 8-12, 
including TGA listed tablets (S11, S12)The HPLC condition for determination of these 
compounds was described in Chapter 2. 
 
These chromatograms tentatively identify the peaks of the marker compounds based 
on retention time and comparison of UV spectrum as shown in Figure 3-6 with S4 as 










































The peaks with the matching retention times to the mixed standards have similar UV 
spectrum. The identification of the small peaks is considered only tentative as some 
are close to detection limit as the lower concentration of the compounds in the sample 
makes it more difficult to compare the UV spectrum as at low absorbance.  In general, 
the results indicate that the catechin markers exist in green tea samples tested. 
However, the profile these markers varied significantly, with certain maker’s absence 
in several products.  Thus, further quantification analysis of these markers was 
conducted to assess the changes of their contents and relationship to the quality of 
green tea products.  
 
Figure 12: HPLC overlay of S4 and the mixed standard 
 
 
The peaks having matching UV spectrum and RT compared to the reference standards 














































3.3 Quantification of marker compounds by HPLC-PDA 
 
In order to quantify the content of maker compounds in the green tea products a series 
of dilution of the marker compounds are used to establish a calibration curve. For 
quantification purposes the calibration curve should be linear over the range used for 
quantification. Figure 11 shows the calibration curves of each marker compound 















Figure 13: Calibration curves of purified chemical markers for quantification of 





Excellent concentration- peak area linear relationship were observed for all marker 
compounds, with r2 between 0.992 to 0.999.  The relevant equations were obtained 
(Table 8) based on the calibration curve of each compound, and used to calculate the 
concentration of each analyte in the green tea samples.   
 
Table 8: Calibration equations for calculation of the content of marker compounds in 
green tea samples, based the data shown in Figure 3.6-8. 
Marker compound Equation r2 value 
Gallic Acid y= 16790155.3959x - 8.9194 0.9999 
Gallocatechin Y=1535455.5914x – 
3671.6042 
0.9995 
Epicatechin Y= 32473152688x 
+2654.3333 
0.9998 
Epicatechin gallate y = 9,791,007.8731x - 
859.2312 
0.9998 
Epigallocatechin y = 2,018,035.6989x - 
10,574.0833 
0.9986 
Epigallocatechin gallate y = 8,235,102.1505x - 
29,739.7083 
0.9992 
Caffeine y = 17,729,821.9355x + 
3,190.0000 
0.9998 












Figure 14: Content of marker compounds in green tea products, determined using the 






In general, the content of each marker compound varied with different green tea 
products. EGCG account for ~50% of taotal catchin, in agreement with (35). The 
highest contents of markers were observed for two manufactured TGA listed products 
(S11 and S12), while the lowest content was also observed for sachet product (S10). 
This product is claimed as 20-50 times more potent than the traditional green tea 
products, while in fact it is the lowest quality tested, with all marker compounds below 
the traditional tea leave products/tea bags. Among the different products, the 
traditional tea leaf products (S3, S4, S5, S6 and S7) showed a higher level of marker 
contents than the tea powder products (Matcha, S1 and S2). Within the same product 
group, eg traditional tea leave products, S4 and S5 showed a higher level of most 
marker compounds than other products. The overall ranking of the products in each 
group are as follows:  tea leave products: S4>S5>S7>S6=S3; tea powder product: 
S2≥S1; The TGA listed products: S9>S8>S11.   For each marker compound, the rank 
orders are as follows. Gallic acid: S12>S11>S9>S5>S3>S6; ECG: 
S11=S12>S9>S5>S4>S1; Epicatechin: S12>S11>S9>S8>S4; Caffeine: 
S8>S5>S4=S7=S1=S12; Theobromine: S8>S5>S7>S12=S4; GC: 
S12>S8>S5>S4>S9>S11; EGC: S12>S8>S4>S11; EGCG: S12=S11>S9>S8>S5=S4;      
 
The results are shown in Table 9.
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Table 9: Chemical content among different products 
Sample number 
Gallic Acid (mg/g) ± 
SD 
GC 
(mg/g) ± SD 
Theobromine 
(mg/g) ± SD 
EGCG (mg/g) ± SD EGC (mg/g) ± SD 
Caffeine (mg/g) ± 
SD 
ECG (mg/g) ± SD 
EC 
(mg/g) ± SD 
S1 0.37±0.00 1.73±0.14 0.22±0.00 44.09±0.07 18.68±0.01 19.30±0.09 9.94±0.01 6.17±0.00 
S2 0.21±0.00 2.12±0.00 0.11±0.00 41.41±0.08 25.03±0.00 13.53±0.03 8.20±0.01 6.59±0.16 
S3 0.62±0.00 2.27±0.03 0.36±0.00 32.84±0.30 17.44±0.08 20.40±0.05 8.17±0.05 5.64±0.23 
S4 0.22±0.00 7.87±0.01 0.93±0.00 53.06±0.10 50.69±0.14 21.77±0.07 15.42±0.04 15.30±0.04 
S5 0.77±0.00 8.99±0.01 1.35±0.00 56.29±0.26 29.00±0.1 24.82±0.04 18.91±0.06 10.11±0.02 
S6 0.16±0.03 1.93±0.00 0.15±0.00 27.57±0.11 25.41±0.07 10.31±0.0 5.46±0.01 6.58±0.02 
S7 0.43±0.00 5.76±0.00 1.10±0.00 38.79±0.14 18.80±0.02 23.54±0.01 12.00±0.01 5.80±0.00 
S8 0.13±0.00 0.64±0.00 0.10±0.00 7.15±0.00 5.39±0.00 3.65±0.00 0.83±0.00 1.09±0.00 
S9 0.26±0.00 0.61±0.00 0.03±0.00 9.52±0.02 2.89±0.01 0.22±0.00 1.90±0.00 1.53±0.00 
S10 0.10±0.00 0.26±0.02 0.01±0.00 1.56±0.01 0.72±0.01 0.79±0.00 0.27±0.00 0.20±0.01 
S11 0.35±0.00 0.49±0.00 0.03±0.00 13.26±0.03 3.21±0.01 0.34±0.00 2.81±0.01 1.93±0.00 
Some of the products had claims made about the concentration of the extract. The results have been calculated as a percentage of the claimed value 



























87.02% 41.41 0.670864736 47.73% 36.81% 14.14% 88.55% 68.38% 75.87% 

















EGCG (%) EGC (%) ECG (%) EC (%) 
S8 ECGC, total 
catechins. 
2.61% 2.45% 74.48% 121.59% 49.10% 52.89% 78.47% 0.28% 0.52% 2.61% 
S9  ECGC 17.40% 5.17% 0.08% 4.28% 0.82% 0.28% 0.74% 114.81% 127.64% 17.40% 
S10 
5g of dry 
leaf 
powder 





6.29% 7.21% 0.12% 5.76% 0.66% 0.28% 0.82% 1.70% 1.61% 6.29% 
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It can be seen in Figure 14 and Table 9 that the levels of most the marker compound 
are well below the expected value based on the lable claims.  
These results indicate that the level of marker compounds changes significantly among 
different green tea products. Given that these marker compounds are related to the 
quality of green teas (see Chapter 1), the results further indicate that the quality of 
green tea products on the market varies significantly. It is surprising to observe that 
one green tea sachet product, which claimed to be potent and equal up to 20 cups of 
green tea per sachet is actually the lowest quality among the product tested, even lower 
than the traditional tea bags. Thus the consumer should be alerted when choosing the 
green tea products, not totally believe the product labels. There is not a necessary link 
between high price and high quality. Based on these findings further tests are 
warranted to analyse a wider range of green tea products for their quality. More random 
testing should be conducted by TGA and authorities to ensure the listed product has a 
quality match their labels. 
 
Many of the products make claims around the concentration in terms of equivalence 
to raw green tea. Making statements like “20X extract”. The Phytochemical results 
were normalised to account for the concentration of the extract based on the label 
claims. For example, a 20X extract claim was divided by 20 to allow direct comparison 
to the raw green tea. Sample 1-7 are raw teas and 8-12 were adjusted based on their 








Figure 15: The content of selected marker compounds with green tea extracts (S8-S11) 

































































































































It can be seen in Figure 15 that when compenstated for their label claims most products 
and markers are well below the expected abundance-in comparison to raw tea samples. 
 
HPLC is a common and accurate technique for the qantificaition however it cannot 
detect all compounds. One of the major reported active in green tea is an ammino acid 
L-theaninie that cannot be detected at the levels present in green tea by HPLC-PDA. 
Therefore a LC-MS method was develop to quantify it. 
 
3.4 Quantification of L-theanine by LCMS 
 
L-theanine is an amino acid and commonly found in green tea leaves(8). Theanine is 
an important marker compound because there is a lot of research interest in the calming 
effect of the amino acid L-Theanine and is an important response for the activity of 
green tea(8,14,30,51).  
 
Although HPLC-PDA is a relatively straight forward method and has been used for 
the other analytes, there are some limitations. Photo-Diode Array (PDA) detection 
requires the molecule of interest to have a chromophore so it absorbs the UV light. 
This part of the molecule is usually defined by areas of conjugation in the chemical 
structure. The chemical structure of theanine lacks a chromophore, thus it does show 
a peak response on the PDA.  
 
The analysis of L-theanine cannot be conducted by conventional HPLC-PDA method 
as the L-theanine lack chromophores it must be present in large quantities to be 
quantified (52). To overcome these problems, in this study we used a LC-MS method 
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which is more sensitive and accurate, and has been sued in previous studies in analysis 
of tea products. 
Figure 3-11 shows the calibration curves of L-theanine. Based on this, the equation 
was calculated and used to determine the content of L-theanine  in the green tea 
samples, and shown in Fig 3.8B.  
 
Figure 16: Determination of L-theanine in green tea products. Calibration curves (A) of 
purified compound and content determination in green tea products (B). Data were 
presented as means of duplicate 
 
 
As Figure 14 shows, the content of L-theanine changed significantly among different 
products, with the highest level observed in sample 7 and 5, followed by Sample 1. 
Three samples (S6, S8 and S9) showed undetectable level of L-theanine.This is to be 
expected because the extract was not standardized to contain L-theanine. The L-
theanine seems to be present in high concentrations in the green tea leaves, rather than 
the powdered Matcha and the green tea extract tablets. Matcha is expected to be 
different in composition from tea leaves, as it is prepared by being compressed and 
powdered as opposed to dried leaves. 
 
The green tea leaves also contain caffeine at relatively high concentrations in 
comparison to the other sample types based on the HPLC data, these may be related. 
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In a study discussed in section 1.4.5, theanine has been discovered to have the opposite 
effect of caffeine(30).   
 
 Interestingly, L-theanine was not detectable in TGA listed green tea tablets (S8 and 
S9) which contained higher level of other marker compounds (see section 3.3).  This 
indicates the manufacture procedure may affect the level of L-theanine in the final 





3.4 Antioxidant Activity 
 
3.4.1 DPPH Radical Scavenging Assay 
 
The total antioxidant activity of the green tea products were studies using the method 
described in Chapter 2. DPPH (2,2-diphenyl-1-picrylhydrazyl) is a radical compound 
with strong absorbance at 515 nm. Hydrogen donating antioxidants reduce DPPH free 
radicals, diminishing their absorbance at 515 nm. The antioxidant activity of green tea 
samples was expressed as equivalent of a standard antioxidant gallic acid. Figure 15 
shows the standard concentration response curve of gallic acid, with a liner repression 
equation calculated which was used to calculate the antioxidant activity of green tea 
samples. The eight-point calibration curve was linear (R2 = 0.9998) from 4.1 to 52.4 





Figure 17: Antioxidant activity of gallic acid  - concentration – response  curve 
 
 
The antioxidant activity of green tea products were calculated as gallic acid equivalent 
(µg) / green tea material (mg), calculated for each sample and shown in Figure 16.  
 
Figure 18: Antioxidant activity of green tea products determined by DPPH assay. See 
Chapter 2 for method. Data were expressed as means and s.e.m.  n=?=3 
 
 
























Gallic Acid activity with DPPH 
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The µg (gallic acid) / mg (herbal material) was calculated for each batch using the 
calibration curve. The results are shown in Table 10. 
 
Table 11: Antioxidant activity of green tea products (DPPH) 
Sample Number Gallic acid equivalence (µg/mg ± SD) n=9 
S1 34.2 ± 0.2 
S2 38.8 ± 0.3 
S3 37.2 ± 0.5 
S4 58.3 ± 1.3 
S5 52.9 ± 1.3 
S6 35.1 ± 0.5 
S7 45.4 ± 0.9 
S8 180 ± 19 
S9 223.6 ±5.6 
S10 35.8 ± 0.6 
S11 584 ± 290 
 
As shown, the antioxidant activity varies with different green tea products. The highest 
antioxidant activity was observed for S11, followed by S9 and S8. This was not 
surprising as the S8,S9 and S11 are all manufactured products using concentrated 
green tea extract as “active” components. However, the lowest antioxidant activity was 
doing for another manufactured product S10. These results are consistent with the 
findings on marker content as described above. This it is highly possible that the 
antioxidant activity of the green tea products is related to the content of marker 




DPPH is one measure of chemical measure of antioxidants. Antioxidants can occur via 
different mechanisms; therefore, the FC assay was used as a second measure of 
antioxidants. 
 




Folin Ciocalteu assay measures the total phenolic content (TFC) or anti-oxidant 
capacity of testing samples. Using the method as described in Chapter 2, The total 
phenolic content of the green tea samples were measure and shown in Figure 17 and 
Table 11. In these experiments S10-S12 were not tested due to the availability of the 
sample and to remaining consistent for comparison with the online phenolics assay. 
    
 
Figure 19: Total phenolic content of green tea products determined by Folin Ciocalteu 

































Table 12: Antioxidant activity of green tea products (TP) 
Sample Number Gallic acid equivalence (µg/mg) n=9 
S1 3.3 ± 0.2 
S2 3.7 ± 0.2 
S3 3.1 ± 0.1 
S4 5.2 ± 0.4 
S5 4.4 ± 0.1 
S6 2.4 ± 0.1 
S7 3.7 ± 0.1 
S8 9.8 ± 1.0 
S9 9 ± 2 
 
 
The highest TPC was observed for the manufactured products (8-9). The traditional 
green tea leaf and powder products (S8 and S9) showed a lower TPC. This is expected 
as seen with the results of in vitro anti-oxidant activity. For example, S8 and S9 
contained relative high level of catechins, which correlated to a relatively high TPC. 
This further suggests that phenolic content plays a large role in the antioxidant activity 
of natural products, as learned from previous works on the chemical composition of 
natural products such as teas and fruit extracts, and it is not clear what type of green 
tea extract was used in these products. Further characterisation of phenolic compounds 
in these products may shed more light on this. 
 




In order to establish the relationship of maker compounds to the antioxidant activity 
of the green tea products, series of correlation analysis were conducted.   
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Figure 3-15 shows the correlation analysis between the content of catechin markers 





Figure 20: Correlation between the content of individual marker compounds and the 
antioxidant activity, based on the data in Figure 3.7 and Figure 3.10. Significant 




 There is a significant positive correlation between the total content of group catechin 
markers (GA, EGC, EC, ECG) with the antioxidant activity, indicating these 
compounds may directly link to the antioxidant activity of green tea products. 
Individual analysis revealed that a strong correlation between the content of GC, GA 
and EGC with the antioxidant activity, less with that of EGCG, ECG and EC. The 
present findings support the use of gallic acid as a marker for the antioxidant content 
of many extracts such as fruits, berries and tea(15). In addition, the findings indicate 
some catechin compound such as GC may be a better maker than GA.  Based on 
these results it can be observed that there is a strong correlation between the 
concentrations of these marker compounds in the tea samples and the antioxidant 
activity in vitro. These marker compounds were selected and compared because they 
all are part of the same class of compounds, catechin polyphenols.  
 
In contrast, other compounds present in tea, methylxanthines caffeine and 
theobromine, did not show a significant correlation with the antioxidant activity as 
shown in Figure 3.14. Similar results were obtained for L-theanine, no correlation was 
observed for its content with the antioxidant activity (Figure 18).  
 
When the selected marker compounds were combined (GA+EC+ECG+EGCG), a 




Figure 21: Correlation between the content of selected markers 
(GA+EC+ECG+EGCG) and the in vitro antioxidant activity. r=0.8229, p<0.01 
 
 
However, the correlation coefficient value (r2) was not further improved, indicating 
that using well selected individual markers, for example gallic acid or EGCG, can 
achieve the same or even better predication of the in vitro antioxidant activity then 
using a group of marker compounds.  These results further indicate that these markers 
can be used as a quality control indicator for the antioxidant activity of the green tea 
products. It should be pointed that the correlation of the marker compounds with the 
anti-oxidant activity also depends on the type of green tea products.  For example, the 
green tea leaf and powdered tea products showed a stronger correlation between the 
content of the caffeine and theobromine with the antioxidant activity of the samples, 
whereas TGA listed tablet products did not show a correlation with caffeine content 
and antioxidant activity since the caffeine appears to have been intentionally reduced 
in some of these products as indicated in the product label, or part of the manufacturing 





There was a strong positive correlation (r2=0.97) between the content of EGCG and 
the total phenolic content. This is similar to the DPPH antioxidant result, which shows 
that phenolic compounds have a significant effect on the antioxidant activity of green 
tea. It was expected that ECGC had the strongest correlation as it is commonly found 
in a number of studies as a major active component of green tea and quote as the active 
ingredient in a number of TGA listed green tea dietary supplements, such as sample 9-
11 that were tested in this study. 
 
The methylxanthine compounds, caffeine and theobromine, did not have as a strong 
of a correlation due to the nature of this class of compounds. In contrast to the catechins 
and gallic acid, these compounds do not contain hydroxyl groups, which are 
characteristic of the type of phenolic compounds that can be detected by this method 
and there for are not suited to this method. 
 
The results of the total phenol assay match the correlations observed for DPPH. Figure 








     
  
Figure 22: Correlation between the content of marker compounds and the total 
antioxidant capacity (total phenolic content), based on the data in Figure 3.7 and 







































































































































































The amino acid L-theanine showed no significant correlation with the DPPH or TC 
 




Figure 23: Correlation between the content of L-theanine and the in vitro antioxidant 





3.7 Online Antioxidant Assay 
 
3.7.1 Online FRAP 
 
Using the method described in the Chapter 2.3.4, a specific online assay was developed 
and shown to be effective to identify the potential antioxidant component/compound 
in complex green tea extracts. Figure 3.17 shows the HPLC chromatogram of the UV 
(280nm) and FRAP (593nm) responses for the green tea product (sample 4). As it 
shows, efficient separations and clear antioxidant responses were observed for the 
main peaks of the green tea sample. This result is consistent with those from the in 
vitro antioxidant activity assay as discussed above, with the markers (eg GA, EC, EGC 
and EGCG) strongly correlated with the in vitro anti-oxidant activity was also found 
to be active in the online FRAP assay. The results indicate that the online method is 
efficient to identify known or unknown component/compounds with antioxidant 
activities. One peak of significant interest in this investigation is peak 2, gallocatechin. 
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This peak showed a low absorbance in the UV range, in contrast with a relatively large 
response with the FRAP reagent. 
 
Most previous studies on the antioxidant potential has been determined by 
conventional colorimetric assays such as DPPH, FRAP and ORAC assays(44,53–55). 
These “benchtop” assays measure the total antioxidant potential of a herbal mixture 
such as green tea, but lack the specificity in determining the marker compound that is 
contributing to the response.  
The online antioxidant assay is a relatively novel approach and powerful tool to study 
the antioxidant activity of complex natural mixtures, and make it possible to identify 
particular ingredients/compounds with antioxidant activity which otherwise not be 
able detect using crude extracts and conventional antioxidant assays. It provides a 
much better understanding of the efficacy of each marker compound and its suitability 
in being an ideal marker for the quality of green teas in terms of antioxidant potential. 
Due to limitations in the cost of this method in terms of availability of additional 
instrumentation and resources, as well as addition training in more complex method, 
this method of antioxidant screening less widespread in the commercial assessment of 
green tea quality. 
 
 
 In the experiment, ferric reducing/antioxidant power (FRAP) assay was used due to 
complications with the DPPH reagent and the online system in our initial experiment. 
Further study will be needed to sue the DPPH online assay to compare with the results 
from conventional in vitro antioxidant assay. Nevertheless, no obvious discrepancy 
was observed these initial experimental results. Previous studies also demonstrated 
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that  DPPH and FRAP assays did not show vast differences in their determination of 
the antioxidant content of guava fruit extracts (56). 
 
Similarly, described in the Chapter, an online assay was also explored for the Folin 
Ciocalteu assay. As show in Figure 19 and Figure 20, efficient separations and clear 
phenolic content responses were observed for the main peaks of the green tea sample. 
The result is consistent with those from the in vitro antioxidant activity assay as 
discussed above, with the markers (eg EC, ECG and EGCG) correlated with the TPC 
was also found to be active in the online FRAP assay. The results indicate that the 
online method is efficient to identify components/compounds potentially affecting the 
antioxidant capacity.  
 
In figure 22, where there is a FRAP peak with the same retention time as peak number 
4, for example, in the UV chromatogram, this means that peak 4 is responsible for the 
then the substance indicated by that peak is responsible for the FRAP activity. This is 
the same for the other peaks of interest labelled in the figure and the corresponding 





Figure 24: HPLC chromatogram of the UV (280nm) and FRAP (593nm) responses for 
green tea product (sample 4). 
 
Figure 25: HPLC chromatogram of the UV (280nm) and FRAP (593nm) antioxidant 





The chromatogram in figure 23 is a chemical profile of a typical green tea sample and 
its antioxidant activity, zoomed to 500mAU. 
 
Catechins are ordered based on their antioxidant activity as indicated by a number of 
studies: EGC ~ EGCG >> ECG = EC > catechins and the number of hydroxyl groups 
is the major factor contributing to antioxidant potential of catechins of green 
tea(39,40). This is in agreement with our results. 
 
It would be ideal to have used DPPH in the online assay to compare to the benchtop 
assays, however due to complications with the DPPH reagent and the online system, 
this was not possible. Based on the work of Thaipong et al. the DPPH and FRAP assays 
did not show differences in their determination of the antioxidant content of guava 
fruit extracts (56). It is possible that similar conclusions can be drawn for tea. DPPH 
and FRAP both detect antioxidants. Direct comparison to the same antioxidant reaction 
is preferred and was achieved for the TPC. 
 
 
3.5.2 Online assay on phenolic content 
 
 
To directly compare to the TPC result and online TP HPLC assay was developed for 
green tea. The chromatogram is shown in Figure 26. Sample 4 was selected as an 
example as it had the highest phenolic response in the F-C assay as well as having 
relatively high concentrations of the marker compounds. This figure shows that there 
is a high UV absorbance of EGCG and Caffeine which corresponds to a higher 
phenolic response in comparison to other peaks in the sample. This is expected as in 
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previous studies, ECGC has been found to be an abundant polyphenol in green tea and 




Figure 26: HPLC Chromatogram of the UV (280nm) and phenolic content (500nm) of 
the green tea sample 4. 
 
 
Figure 27: HPLC Chromatogram of the UV (280nm) and phenolic content (500nm) of 








The online antioxidant assays allowed the identification of the chemicals responsible 




There are some limitations of the present study. Firstly, due to the time limit, we have 
only sourced limited number of green tea samples. It is not clear if the correlations as 
demonstrated in this study can be extended to other green tea products. Thus the 
findings from this study need to be further confirmed by analysis of more green tea 
products. Secondly, the antioxidant activity assay used (DPPH assay) is useful but it 
is in vitro in nature. It has been known that some findings in vitro can be transformed 
directly into an in vivo situation. Thus, further research is needed to study the 
relationship of the marker compounds with in vivo antioxidant activity to confirm the 
correlation established has a general implication. Thirdly the online antioxidant assay 
is promising, but it is only a pilot study. Further research is needed to optimize the 
assay condition and then apply to various green tea samples for testing. It is highly 
possible the online method may reveal important aspects of quality markers and 
important links between chemical compositions to bioactivities.  In addition, we did 
not fully characterise the chemical compositions of each green tea product, thus it is 
not clear if any other known or unknown compounds are involved in the observed 
antioxidant activity. It is possible that further research may discover more active 
compounds in the green teas which may have a better correlation to the antioxidant 
activity in vitro and in vivo. A further limitation is that the methods have not had inter-
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laboratory validation and therefore will need to be confirmed by other laboratories for 





In conclusion, the findings from this study have clearly demonstrated that there is a 
close relationship between the content of certain chemical markers to antioxidant 
activity of green tea products. Those markers, in particular certain catechins such as 
gallic acid, EGCG, EC, EGC, can be used as quality markers for determining the 
quality of various green tea products. In addition, two online assays have been 
successfully developed, which can be used to future research to determine the link 
between known and unknown components/compounds to the antioxidant activity of 
various complex natural extracts/products.  Further research in this area may lead to 
new approaches to study and identify the bioactive compounds from natural products 
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